U.S. Deep Brain Stimulation In Parkinson’s Disease Market Research Report
Chapter 1.Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2.Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3.Executive Summary
3.1.Market Snapshot
Chapter 4.Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1.Raw Material Procurement Analysis
4.3.2.Sales and Distribution Channel Analysis
4.3.3.Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on U.S. Deep Brain Stimulation In Parkinson’s Disease Market
5.1.COVID-19 Landscape: U.S. Deep Brain Stimulation In Parkinson’s Disease Industry Impact
5.2.COVID 19 - Impact Assessment for the Industry
5.3.COVID 19 Impact: Global Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6.Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1.Market Drivers
6.1.2.Market Restraints
6.1.3.Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1.Bargaining power of suppliers
6.2.2.Bargaining power of buyers
6.2.3.Threat of substitute
6.2.4.Threat of new entrants
6.2.5.Degree of competition
Chapter 7.Competitive Landscape
7.1.1.Company Market Share/Positioning Analysis
7.1.2.Key Strategies Adopted by Players
7.1.3.Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8.Global U.S. Deep Brain Stimulation In Parkinson’s Disease Market, By Product
8.1.U.S. Deep Brain Stimulation In Parkinson’s Disease Market, by Product Type, 2020-2027
8.1.1.Single-channel
8.1.1.1.Market Revenue and Forecast (2016-2027)
8.1.2.Dual-channel
8.1.2.1.Market Revenue and Forecast (2016-2027)
Chapter 9.Global U.S. Deep Brain Stimulation In Parkinson’s Disease Market, Regional Estimates and Trend Forecast
9.1.U.S.
9.1.1.Market Revenue and Forecast, by Product (2016-2027)
Chapter 10.Company Profiles
10.1.Boston Scientific Corporation
10.1.1.Company Overview
10.1.2.Product Offerings
10.1.3.Financial Performance
10.1.4.Recent Initiatives
10.2.Abbott
10.2.1.Company Overview
10.2.2.Product Offerings
10.2.3.Financial Performance
10.2.4.Recent Initiatives
10.3.Medtronic
10.3.1.Company Overview
10.3.2.Product Offerings
10.3.3.Financial Performance
10.3.4.Recent Initiatives
10.4.Functional Neuromodulation
10.4.1.Company Overview
10.4.2.Product Offerings
10.4.3.Financial Performance
10.4.4.Recent Initiatives
10.5.Nuvectra Corporation
10.5.1.Company Overview
10.5.2.Product Offerings
10.5.3.Financial Performance
10.5.4.Recent Initiatives
10.6.Aleva Neurotherapeutics SA
10.6.1.Company Overview
10.6.2.Product Offerings
10.6.3.Financial Performance
10.6.4.Recent Initiatives
Chapter 11.Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12.Appendix
12.1.About Us
12.2.Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers